MAPT and tauopathy: As Tau protein in the cerebrospinal fluid can be used as an early disease detection marker of tauopathy (www.alzforum.org/alzbiomarker) [112], the strategies to untangle tauopathy can be classified into two main groups: Tau-based or non-Tau-based.